期刊文献+

HPV感染及IL-1β、IL-6、IL-13的表达与子宫颈癌临床相关性分析 被引量:19

Relationship between HPV infection,expression of IL-1β,IL-6,IL-13 and the developing of cervical cancer
下载PDF
导出
摘要 目的探讨子宫颈癌组织中的人乳头瘤病毒(human papilloma virus,HPV)感染及IL-1β、IL-6、IL-13的表达与临床病理资料的相关性。方法选取76例子宫颈癌组织,采用组织芯片技术、免疫组织化学技术及统计学技术,对检测HPV、IL-1β、IL-6、IL-13的各个指标间进行比较分析。结果 HPV、IL-1β、IL-6、IL-13的高表达与子宫颈癌患者术前有无化疗有相关性(P<0.01),与其它的临床病理资料无相关性。结论子宫颈癌术前经过一段时间的化疗,不但能使肿瘤缩小,还能抑制炎症因子的表达,预防肿瘤的复发。 Objective To discuss the correlation of HPV infection in cervical carcinoma, ex- pression of IL-1β, IL-6, IL-13, and their clinicopathologic data. Methods Seventy-six sam- ples of cervical carcinoma which tissues were collected from the Third Affiliated Hospital of Harbin Medical University since March to September in 2012. Tissue microarray technology, immunohistochemical technique and statistic technology were adopted to make comparative analysis of indexes for HPV, IL-1β, IL-6 and IL-13. Results The high expression of HPV, IL-1β, IL-6 and IL-13 correlated with the existence of patients' preoperative chemotherapy (P 〈 0.05), but had no correlation with other clinicopathologic data. Conclusion Chemotherapy for a period of time before cervical carcinoma operation can not only narrow the turnout, restrain the expression of inflammatory factor, but also prevent the relapse of turnout.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2013年第6期490-494,共5页 Journal of Harbin Medical University
关键词 子宫颈癌 人类乳头状病毒 炎症因子 白细胞介素-1β 白细胞介素-6 白细胞介素-13 cervical cancer human papilloma virus inflammatory factors interleukin-1β interleukin-6 interleukin-13
  • 相关文献

参考文献12

  • 1Scarinci IC, Garcia FA, Kobetz E. Cervical cancer prevention: new tools and old barriers[ J]. NIH Public Access Cancer, 2010, 116 ( 11 ) :2531-2542.
  • 2Graham JC, Zarbl H. Use of cell-SELEX to generate DNA aptam- ers as molecular probes of HPV-Associated cervical cancer cells [J]. PLoS ONE, 2012,7(4):e36103.,.
  • 3Chen HC, You SL, Hsieh CY, et al. Prevalence of genotype-spe- cific human papillomavirus infection and cervical neoplasia in Tai- wan: a community-based survey of 10602 women[ J]. Int J Canc- er, 2011,128(5) :1192-1203.
  • 4Benard VB, Watson M, Castle PE, et al. Cervical carcinoma rates among young females in the United States [ J ]. Obstet Gynecol, 2012,120(5) :1117-1123.
  • 5Johansson C, Schwartz S. Regulation of human papillomavirus gene expression by splicing and polyadenylation [ J ]. Nat Rev Mi- crobial, 2013,11 (4) :239-251.
  • 6Ramos CA, Narala N, Vyas GM, et al. Human papillomavims type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive im- munotherapy of HPV-associated malignancies [ J ]. J Immunother, 2013,36( 1 ) :66-76.
  • 7Chen HC, Schiffman M, Lin CY. Persistence of type-specific hu- man papillomavirus infection and increased long-term risk of cervi- cal cancer[ J]. J Natl Cancer Inst, 2011,103 ( 18 ) : 1387-1396.
  • 8Qian N, Chen X, Han S, et al. Circulating IL-1 beta levels, poly- morphisms of IL-1 β, and risk of cervical cancer in Chinese women [J]. J Cancer Res Clin Oneol, 2010,136(5) :709-716.
  • 9Muraguchi A, Hirano T, Targ B, et al. The essential role of B cell stimulatory factor 2 ( BSF-z/IL-6 ) for the terminal differentiation of B cells[J]. J Exp Med, 1988,167(2) :332-344.
  • 10Xu J, Yin Z, Cao S, et al. Systematic review and meta-analysis on the association between IL-1β polymorphisms and cancer risk [J]. PLoS One, 2013,8(5) :e63654.

同被引文献134

  • 1Hossein R, Behzad S, Tahar M, et al. Prevalence of human papillomavirus genotypes associated with cervical and breast cancer iniran [ J]. Monoclon Antib Immuno- diagn Immunother, 2013,32(6) :399 -403.
  • 2Arbyn M, Ronco G, Anttila A, et al. Evidence regard- ing human papillomavirus testing in secondary prevention of cervical cancer [ J ]. Vaccine, 2012, 30 ( 5 ) : 88 - 99.
  • 3Vandecasteele K, Makar A, Vanden Broecke R, et al. Intensity-modulated arc therapy with clsplatin as neo- adjuvant treatment for primary irresectable cervical canc- er Toxicity, tumour response and outcome [ J]. Strahl- entherapie und Onkologie, 2012,188 (7) :576 - 581.
  • 4Bendetti Panici P, Greggi S, Colombo A, et al. Neoadju- vant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian muhicenter randomized study [ J]. Journal of Clinical Oncology,2001,17 (20) : 179 - 188.
  • 5Neoadjuvant Chemotherapy for locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chem- otherapy for locally advanced cervical cancer: a systemat- ic review and recta-analysis of individual patient data from 21 randomized trials [ J ]. European Journal of Cancer,2003,39( 17 ) :2470 - 2486.
  • 6Benedetti Panici P, Bellati F, Pastore M, et al. An up- date in neoadjuvant chemotherapy in cervical cancer [ J ]. Gynecologic Oncology, 2007,107 ( 1Sll ) :20 - 22.
  • 7September AV,NeU EM,O' Connell K et al.A pathway-based approach investigating the genes encoding interleukin-lbeta, interleukin-6 and the interleuldn-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy. [J].British journal of sports medicine,2011,45 (13): 1040-1047.
  • 8Lopes,C.O.,Callera,F..Three-dimensional conformal radiotherapy in prostate cancer patients: Rise in interleukin 6 (IL-6) but not IL-2, IL-4, IL-5, tumor necrosis factor- α, MIP-1-α, and LIF levels[J].International Journal of Radiation Oncology, Biology, Physics,2012,82(4):1385-1388.
  • 9张甜甜,王朝霞,马才媛,等.IL-24联合顺铂对宫颈癌移植瘤生长抑制及侵袭力的影响[J].中华临床医师杂志(电子版),2013,(24):11553-11558.
  • 10Vega-Pea A,Illades-Aguiar B,Flores-Alfaro E,et al.Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6,Ki-67,and telomerase[J].J Cytol,2013,30(4):226-232.

引证文献19

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部